ArticleThe oncologist2025

Pegylated liposomal doxorubicin in partially platinum-sensitive, platinum-resistant, or platinum-refractory ovarian cancer: a prospective study.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.